Literature DB >> 21958786

A comparison of outcome in patients with preoperative atrial fibrillation and patients in sinus rhythm.

Saina Attaran1, Matthew Shaw, Laura Bond, Mark D Pullan, Brian M Fabri.   

Abstract

BACKGROUND: Approximately 10% to 15% of patients undergoing cardiac operations suffer from atrial fibrillation (AF) at the time of surgery. The current risk stratification methods do not include preoperative arrhythmias. The aim of this study was to assess the effect of preoperative AF on the immediate postoperative outcome of patients undergoing cardiac surgery as well as in the midterm and long-term outcomes.
METHODS: We reviewed patient data for our institution for a 10-year period; a total of 14,320 patients undergoing any cardiac operation were included; 12,395 (86.5%) had sinus rhythm preoperatively and 1,925 (13.5%) were in persistent AF. After propensity matching and adjusting for the preoperative and operative characteristics, 1,800 patients remained in each group and were compared.
RESULTS: Before and after adjusting for the preoperative and operative characteristics, inotropic support, ventilation time, renal failure, stroke, and surgical wound infection rates were all significantly higher for the patients with AF (p < 0.001). Intensive care unit stay and hospital stay as well as in-hospital mortality were also significantly higher among the patients with AF compared with the sinus rhythm group (p < 0.001). At 30 days, 5-year and 10-year mortality rates in the AF group were significantly higher compared with those in sinus rhythm group (p < 0.001).
CONCLUSIONS: Atrial fibrillation preoperatively is associated with a higher incidence of postoperative complications. This arrhythmia is an important variable that appears to have been excluded from the current risk stratification systems. Our experience suggests that AF should be considered in the development/update of risk-stratifying methodologies to improve the predictive accuracy.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21958786     DOI: 10.1016/j.athoracsur.2011.04.119

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

Review 1.  Preventing deep wound infection after coronary artery bypass grafting: a review.

Authors:  Charles S Bryan; William M Yarbrough
Journal:  Tex Heart Inst J       Date:  2013

2.  Predictors for long-term outcome and quality of life of patients after cardiac surgery with prolonged intensive care unit stay.

Authors:  Christina Grothusen; Tim Attmann; Christine Friedrich; Sandra Freitag-Wolf; Nils Haake; Jochen Cremer; Jan Schöttler
Journal:  Interv Med Appl Sci       Date:  2013-03-19

Review 3.  An update on the prognosis of patients with atrial fibrillation.

Authors:  David D McManus; Michiel Rienstra; Emelia J Benjamin
Journal:  Circulation       Date:  2012-09-04       Impact factor: 29.690

4.  Prevention of postoperative atrial fibrillation: novel and safe strategy based on the modulation of the antioxidant system.

Authors:  Ramón Rodrigo
Journal:  Front Physiol       Date:  2012-04-12       Impact factor: 4.566

Review 5.  Vitamin C revisited.

Authors:  Heleen M Oudemans-van Straaten; Angelique Me Spoelstra-de Man; Monique C de Waard
Journal:  Crit Care       Date:  2014-08-06       Impact factor: 9.097

6.  Outcomes After Non-neurological Surgery in Patients With Parkinson's Disease: A Nationwide Matched Cohort Study.

Authors:  Yu-Feng Huang; Yi-Chun Chou; Chun-Chieh Yeh; Chaur-Jong Hu; Yih-Giun Cherng; Ta-Liang Chen; Chien-Chang Liao
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

7.  Comparison Effect of Tranexamic Acid (TA) and Tranexamic Acid Combined with Vitamin C (TXC) on Drainage Volume and Atrial Fibrillation Arrhythmia in Patients Undergoing Cardiac Bypass Surgery: Randomized Clinical Trial.

Authors:  Koorosh Ghorbaninezhad; Fozieh Bakhsha; Zahra Yousefi; Solmaz Halakou; Zahra Mehrbakhsh
Journal:  Anesth Pain Med       Date:  2019-10-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.